LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Sep 21, 2017
Targets & Mechanisms
Appetite for GFRAL
Why pharmas think GFRAL could be the next obesity target
Read More
BioCentury
|
Jun 23, 2017
Clinical News
Novo’s semaglutide shows obesity benefit in Phase II trial
Read More
BioCentury
|
Mar 7, 2016
Analyst Picks & Changes
Analyst picks & changes
Read More
BioCentury
|
Sep 14, 2015
Finance
Gaining leverage
Reading the tea leaves of Icahn's Vivus debt play
Read More
BioCentury
|
Aug 10, 2015
Company News
Vivus endocrine/metabolic news
Read More
BioCentury
|
Aug 1, 2015
Company News
Vivus to cut Qsymia sales force
Read More
BioCentury
|
Jun 15, 2015
Company News
Vivus, Wal-Mart Stores Inc. sales and marketing update
Read More
BioCentury
|
Apr 23, 2015
Company News
Novo launches Saxenda in the U.S.
Read More
BioCentury
|
Apr 6, 2015
Company News
Vivus endocrine/metabolic news
Read More
BioCentury
|
Dec 24, 2014
Company News
Novo's Saxenda wins FDA approval
Read More
Items per page:
10
1 - 10 of 278